GOFINTECH QUANT (00290) rose over 10% in morning trade. As of the time of writing, the stock was up 9.96% to HK$9.27, with a turnover of HK$53.02 million. The surge follows the company's announcement of a strategic cooperation memorandum of understanding with Meditronix Biotech. The non-binding memorandum aims to advance collaboration in quantum technology-related fields. The two parties intend to cooperate across three key areas under a milestone-based licensing model: jointly operating Meditronix Biotech's Quantum AIDD platform and advancing related asset acquisitions; jointly establishing a Quantum Frontier Technology Investment Fund; and co-building a Quantum Computing Center in Hong Kong. The Board of Directors believes the strategic partnership presents an opportunity for the Group to further explore developments in cutting-edge technology sectors and the potential integration of its resources with Meditronix Biotech's infrastructure, such as the QureGen AI and TyxonQ platforms. It also allows the Group to target fields like drug discovery and new material design by leveraging Meditronix Biotech's existing drug pipeline and quantum AI computing assets, thereby exploring ways to diversify its potential revenue streams.
Comments